InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: jimtash post# 29426

Sunday, 06/28/2015 10:11:20 AM

Sunday, June 28, 2015 10:11:20 AM

Post# of 30046
Who is Pharmaline?


Good Morning Taiwan

You are correct Jim.Onkoresult trade name being used in Turkey by the manufacturer of OS for Uni Pharma..Now a Subsidiary..


On June 6th 2013, we entered into a 5-year license agreement between AMDL Diagnostics, Inc. (“ADI”), a division within our company, and Uni Pharma Co., Ltd. a Taipei Taiwan limited liability company (“UNI”) that provides UNI with a 5-year exclusive license (subject to automatic renewal for an additional 5 years) to RXPC’s Onko-Sure® (formerly called DR-70 cancer blood test kits (the “Tests”), procedures, analyses, data, know how, manufacturing, manufacturing processes, components, trademarks and intellectual property. Pursuant to the terms of the Agreement, the total license fee shall be US$500,000, $100,000 of which UNI shall pay as an up-front license fee ($20,000 upon signing the agreement and $80,000 upon commencement of training UNI personnel at ADI facilities) and the remaining of which, UNI shall pay in 4 equal annual installments over the next 4 years. The License Agreement will become effective upon our receipt of the up-front license fee.

The agreement covers the following territories: China, Hong Kong, Malaysia, Singapore, Indonesia, Thailand, Japan, India, Turkey and Australia and New Zealand. We also agreed not to issue exclusive rights to any other person(s) to sell the Tests in the covered territories during the term of the agreement.



from 4/8/15 (oncoresult, see pics)

Turkey OnkoResult (Pharmaline subsidiary) in the past two to three years to implement DR-70 clinical trials, the results exceeded expectations, supported by many local doctors and teaching hospitals; April in particular to the company to visit, distributor negotiated issues, will actively Government budget execution for people tracking and screening program for colorectal cancer, and gradually applied to other cancers, and help the company to promote the DR-70 to neighboring countries.

http://uni-pharma.com/news_detail-2.html


FW: Our expansion with Onko-Sure happened almost by accident. Initially, we just wanted to distribute the product in Taiwan. We then began to develop within the region to markets like Singapore—but again, just as a distributor. However, we began to realize that we could do more.

There are multiple reasons for our evolution. Firstly, I think it was the right time. The company was looking for a new direction, and Onko-Sure had the right profile. With a pharmaceutical product, we would have had a hard time in Taiwan because of the challenges we would face in development and regulation. For diagnostic products, Taiwan has had significant strengths for at least ten years in OEM. By leveraging that history, and with the great partner that we have in Pharmigene, we can make great strides forward.

Taiwan is a small island. Every company has their unique strengths, but we need to team up in order to grow.


http://pharmaboardroom.com/interviews/interview-terry-lin-general-manager-and-freia-wei-senior-consultant-uni-pharma/


http://www.pharmigene.com/

Contact Info
United States

20112 Edinburgh Dr.,
Saratoga, CA 95070,USA

Tel: +1-650-847-1416
Fax: +1-650-847-1415

customservices@pharmigene.com
Taiwan

4F., No. 17, Ln. 171, Sec. 2, Jiuzong Rd.,
Neihu Dist., Taipei City 114, Taiwan

Tel: +886-2-2798-5885
Fax: +886-2-2798-6300

service@pharmigene.com


http://www.biotecheast.com/modules.php?op=modload&name=News&file=article&sid=2361&topic=2


GO Daddy.....

http://domain-kb.com/www/onkoresult.com

FACE BOOK.........
https://www.facebook.com/onkoresult


And a 5 Star review by the Wizard of OZ Turk you understand...ahooooooooooooooooooooooooooooooooooooooooo

https://www.facebook.com/mehmet.ozturk.98096





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.